📰 Menarini Diagnostics News
Menarini Diagnostics News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Menarini Diagnostics. Real-time updates on events, politics, business and more.
June 2, 2023
The global sales of Continuous Glucose Monitoring Device Market in 2023 are anticipated to be US$ 5.5 Billion, according to Future Market Insights’ recently published Global Continuous Glucose Monitoring Device Market analysis report. The market is expected to be valued US$ 16.8 billion by 2033, with a CAGR of 11.9%...
May 22, 2023
/PRNewswire/ -- A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one,...
May 22, 2023
FLORENCE, Italy, May 22, 2023 /PRNewswire/ -- A.Menarini Diagnostics S.r.l. is pleased to announce the commercial launch of its PRIME MDx platform: a sample-to-result, all-in-one, fully-automated
April 19, 2023
The agreement covers the exclusive distribution of the AFIAS-10 Single Test Immuno-Assay System, including IGRA-Tuberculosis across 34 countries in Europe FLORENCE, Italy, April 19, 2023
April 19, 2023
/PRNewswire/ -- A.Menarini Diagnostics S.r.l. (Menarini) is pleased to announce an exclusive distribution agreement for the AFIAS-10 System and IGRA-TB Assay...
April 8, 2023
Global POC Blood Analyzer Market
March 8, 2023
/PRNewswire/ -- The "Continuous Glucose Monitoring (CGM) Market - Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.coms offering. The...
February 8, 2023
According to Future Market Insights’ newly released Continuous Glucose Monitoring Device Market industry analysis report, global sales of Continuous Glucose Monitoring Device Market in 2022 will be US$ 4.9 Billion. The market is expected to reach a valuation of US$ 16.8 billion by 2033, with a CAGR of 11.9% from 202...
December 14, 2022
/PRNewswire/ -- According to Ariztons latest research report, the electronic skin patches market will grow at a CAGR of 20.17% during 2021-2027. With the...
November 2, 2022
/PRNewswire/ -- QuantuMDx Group Limited ("QuantuMDx"), a UK-based developer of transformational Point-of-Need molecular diagnostics, and A.Menarini Diagnostics...